These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
112 related articles for article (PubMed ID: 28629303)
21. Derivation and validation of the predicting bleeding complications in patients undergoing stent implantation and subsequent dual antiplatelet therapy (PRECISE-DAPT) score: a pooled analysis of individual-patient datasets from clinical trials. Costa F; van Klaveren D; James S; Heg D; Räber L; Feres F; Pilgrim T; Hong MK; Kim HS; Colombo A; Steg PG; Zanchin T; Palmerini T; Wallentin L; Bhatt DL; Stone GW; Windecker S; Steyerberg EW; Valgimigli M; Lancet; 2017 Mar; 389(10073):1025-1034. PubMed ID: 28290994 [TBL] [Abstract][Full Text] [Related]
22. Prognostic implications of early and long-term bleeding events in patients on one-year dual antiplatelet therapy following drug-eluting stent implantation. Musumeci G; Rossini R; Lettieri C; Capodanno D; Romano M; Rosiello R; Guagliumi G; Valsecchi O; Gavazzi A; Angiolillo DJ Catheter Cardiovasc Interv; 2012 Sep; 80(3):395-405. PubMed ID: 22109961 [TBL] [Abstract][Full Text] [Related]
23. Impact of proton pump inhibitors and dual antiplatelet therapy cessation on outcomes following percutaneous coronary intervention: Results From the PARIS Registry. Chandrasekhar J; Bansilal S; Baber U; Sartori S; Aquino M; Farhan S; Vogel B; Faggioni M; Giustino G; Ariti C; Colombo A; Chieffo A; Kini A; Saporito R; Michael Gibson C; Witzenbichler B; Cohen D; Moliterno D; Stuckey T; Henry T; Pocock S; Dangas G; Gabriel Steg P; Mehran R Catheter Cardiovasc Interv; 2017 Jun; 89(7):E217-E225. PubMed ID: 27650638 [TBL] [Abstract][Full Text] [Related]
24. Stent thrombosis and optimal duration of dual antiplatelet therapy after coronary stenting in contemporary practice. Cho MS; Park DW Korean J Intern Med; 2017 Sep; 32(5):769-779. PubMed ID: 28823143 [TBL] [Abstract][Full Text] [Related]
26. Dual antiplatelet therapy in patients with a long coronary artery lesion over 30 mm: Determinants and impact on prognosis. Manchuelle A; Delhaye C; Schurtz G; Sudre A; Hurt C; Bonello L; Puymirat E; Bauters C; Lemesle G Arch Cardiovasc Dis; 2015 Apr; 108(4):235-43. PubMed ID: 25682548 [TBL] [Abstract][Full Text] [Related]
27. Benefits and Risks of Extended Duration Dual Antiplatelet Therapy After PCI in Patients With and Without Acute Myocardial Infarction. Yeh RW; Kereiakes DJ; Steg PG; Windecker S; Rinaldi MJ; Gershlick AH; Cutlip DE; Cohen DJ; Tanguay JF; Jacobs A; Wiviott SD; Massaro JM; Iancu AC; Mauri L; J Am Coll Cardiol; 2015 May; 65(20):2211-21. PubMed ID: 25787199 [TBL] [Abstract][Full Text] [Related]
28. DAPT Score Utility for Risk Prediction in Patients With or Without Previous Myocardial Infarction. Kereiakes DJ; Yeh RW; Massaro JM; Cutlip DE; Steg PG; Wiviott SD; Mauri L; J Am Coll Cardiol; 2016 May; 67(21):2492-502. PubMed ID: 27046159 [TBL] [Abstract][Full Text] [Related]
29. Clinical outcomes of dual antiplatelet therapy after implantation of drug-eluting stents in patients with different cardiovascular risk factors. Lee SY; Hong MK; Shin DH; Kim JS; Kim BK; Ko YG; Choi D; Jang Y; Kim HS; Valgimigli M; Palmerini T; Stone GW Clin Res Cardiol; 2017 Mar; 106(3):165-173. PubMed ID: 27631821 [TBL] [Abstract][Full Text] [Related]
30. Efficacy and Safety of Dual Antiplatelet Therapy After Complex PCI. Giustino G; Chieffo A; Palmerini T; Valgimigli M; Feres F; Abizaid A; Costa RA; Hong MK; Kim BK; Jang Y; Kim HS; Park KW; Gilard M; Morice MC; Sawaya F; Sardella G; Genereux P; Redfors B; Leon MB; Bhatt DL; Stone GW; Colombo A J Am Coll Cardiol; 2016 Oct; 68(17):1851-1864. PubMed ID: 27595509 [TBL] [Abstract][Full Text] [Related]
31. International patterns of dual antiplatelet therapy duration after acute coronary syndromes. Bueno H; Pocock S; Danchin N; Annemans L; Gregson J; Medina J; Van de Werf F Heart; 2017 Jan; 103(2):132-138. PubMed ID: 27504002 [TBL] [Abstract][Full Text] [Related]
32. A randomized clinical trial comparing long-term clopidogrel vs aspirin monotherapy beyond dual antiplatelet therapy after drug-eluting coronary stent implantation: Design and rationale of the Harmonizing Optimal Strategy for Treatment of coronary artery stenosis-Extended Antiplatelet Monotherapy (HOST-EXAM) trial. Lee H; Koo BK; Park KW; Shin ES; Lim SW; Rha SW; Bae JW; Jeon DW; Oh SK; Hur SH; Kim BS; Lee JH; Park TH; Lee NH; Kim HS; Am Heart J; 2017 Mar; 185():17-25. PubMed ID: 28267471 [TBL] [Abstract][Full Text] [Related]
33. Clinical impact of extended dual antiplatelet therapy after percutaneous coronary interventions in the drug-eluting stent era: a meta-analysis of randomized trials. Cassese S; Byrne RA; Tada T; King LA; Kastrati A Eur Heart J; 2012 Dec; 33(24):3078-87. PubMed ID: 23091199 [TBL] [Abstract][Full Text] [Related]
34. ACC/AHA Versus ESC Guidelines on Dual Antiplatelet Therapy: JACC Guideline Comparison. Capodanno D; Alfonso F; Levine GN; Valgimigli M; Angiolillo DJ J Am Coll Cardiol; 2018 Dec; 72(23 Pt A):2915-2931. PubMed ID: 30522654 [TBL] [Abstract][Full Text] [Related]
35. Evaluation of the efficacy and safety of dual antiplatelet therapy with or without warfarin in patients with a clinical indication for DAPT and chronic anticoagulation: A meta-analysis of observational studies. Bavishi C; Koulova A; Bangalore S; Sawant A; Chatterjee S; Ather S; Valencia J; Sarafoff N; Rubboli A; Airaksinen JK; Lip GY; Tamis-Holland JE Catheter Cardiovasc Interv; 2016 Jul; 88(1):E12-22. PubMed ID: 26354765 [TBL] [Abstract][Full Text] [Related]
36. Extended dual antiplatelet therapy for Asian patients with acute coronary syndrome: expert recommendations. Chen WWC; Law KK; Li SK; Chan WCK; Cheong A; Fong PC; Hung YT; Lai SWK; Leung GTC; Wong EML; Wong RWK; Yan CT; Yan VWT; Au Yeong TCK Intern Med J; 2019 Mar; 49 Suppl 1():5-8. PubMed ID: 30815979 [TBL] [Abstract][Full Text] [Related]
37. Warfarin use among older atrial fibrillation patients with non-ST-segment elevation myocardial infarction managed with coronary stenting and dual antiplatelet therapy. Fosbol EL; Wang TY; Li S; Piccini J; Lopes RD; Mills RM; Klaskala W; Thomas L; Roe MT; Peterson ED Am Heart J; 2013 Nov; 166(5):864-70. PubMed ID: 24176442 [TBL] [Abstract][Full Text] [Related]
38. Safety and efficacy of 6-month versus 12-month dual antiplatelet therapy in patients after implantation of multiple biodegradable polymer-coated sirolimus-eluting coronary stents: Insight from the I-LOVE-IT 2 trial. Qi J; Li Y; Li J; Jing Q; Xu K; Gao C; Ma L; Zhang Z; Xu B; Han Y Catheter Cardiovasc Interv; 2017 Mar; 89(S1):555-564. PubMed ID: 28318138 [TBL] [Abstract][Full Text] [Related]
40. 2016 ACC/AHA Guideline Focused Update on Duration of Dual Antiplatelet Therapy in Patients With Coronary Artery Disease: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines. Levine GN; Bates ER; Bittl JA; Brindis RG; Fihn SD; Fleisher LA; Granger CB; Lange RA; Mack MJ; Mauri L; Mehran R; Mukherjee D; Newby LK; O'Gara PT; Sabatine MS; Smith PK; Smith SC J Am Coll Cardiol; 2016 Sep; 68(10):1082-115. PubMed ID: 27036918 [No Abstract] [Full Text] [Related] [Previous] [Next] [New Search]